{"id":"https://openalex.org/W1973150848","doi":"https://doi.org/10.1158/1535-7163.targ-11-cn04-01","title":"Abstract CN04-01: Contribution of polymorphic transporters to oncology drug disposition and safety.","display_name":"Abstract CN04-01: Contribution of polymorphic transporters to oncology drug disposition and safety.","publication_year":2011,"publication_date":"2011-11-01","ids":{"openalex":"https://openalex.org/W1973150848","doi":"https://doi.org/10.1158/1535-7163.targ-11-cn04-01","mag":"1973150848"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.targ-11-cn04-01","doi":"https://doi.org/10.1158/1535-7163.targ-11-cn04-01","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.targ-11-cn04-01","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065279964","display_name":"Alex Sparreboom","orcid":"https://orcid.org/0000-0003-2660-6644","observed_orcids":["https://orcid.org/0000-0003-2660-6644"]},"institutions":[{"id":"https://openalex.org/I1313298211","display_name":"St. Jude Children's Research Hospital","ror":"https://ror.org/02r3e0967","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1313298211","https://openalex.org/I2802152183"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alex Sparreboom","raw_affiliation_strings":["1St. Jude Children's Research Hospital, Memphis, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1St. Jude Children's Research Hospital, Memphis, TN","institution_ids":["https://openalex.org/I1313298211"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077260725","display_name":"Sharyn D. Baker","orcid":"https://orcid.org/0000-0003-3062-3252","observed_orcids":["https://orcid.org/0000-0003-3062-3252"]},"institutions":[{"id":"https://openalex.org/I1313298211","display_name":"St. Jude Children's Research Hospital","ror":"https://ror.org/02r3e0967","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1313298211","https://openalex.org/I2802152183"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sharyn D. Baker","raw_affiliation_strings":["1St. Jude Children's Research Hospital, Memphis, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1St. Jude Children's Research Hospital, Memphis, TN","institution_ids":["https://openalex.org/I1313298211"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1313298211"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"10","issue":"11_Supplement","first_page":"CN04","last_page":"01"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.006200000178068876,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug-transporters","display_name":"drug transporters","score":0.8930000066757202},{"id":"https://openalex.org/keywords/oncology-drugs","display_name":"oncology drugs","score":0.777999997138977},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7490000128746033},{"id":"https://openalex.org/keywords/abc-transporters","display_name":"ABC transporters","score":0.7509999871253967},{"id":"https://openalex.org/keywords/p-glycoprotein","display_name":"P-glycoprotein","score":0.925000011920929},{"id":"https://openalex.org/keywords/mrp1","display_name":"MRP1","score":0.8790000081062317},{"id":"https://openalex.org/keywords/mrp2","display_name":"MRP2","score":0.9779999852180481},{"id":"https://openalex.org/keywords/abcg2","display_name":"ABCG2","score":0.9610000252723694},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.49000000953674316},{"id":"https://openalex.org/keywords/drug-disposition","display_name":"drug disposition","score":0.44200000166893005},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.7139999866485596},{"id":"https://openalex.org/keywords/inter-individual-variability","display_name":"interindividual variability","score":0.6430000066757202},{"id":"https://openalex.org/keywords/drug-development-attrition","display_name":"drug development attrition","score":0.6380000114440918},{"id":"https://openalex.org/keywords/clinical-pharmacology","display_name":"clinical pharmacology","score":0.6039999723434448},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.5429999828338623},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.42399999499320984}],"concepts":[{"id":"https://openalex.org/C38022665","wikidata":"https://www.wikidata.org/wiki/Q1149305","display_name":"Disposition","level":2,"score":0.7387884855270386},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5970878601074219},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5144557952880859},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4228118360042572},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3361199200153351},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.1698944866657257},{"id":"https://openalex.org/C77805123","wikidata":"https://www.wikidata.org/wiki/Q161272","display_name":"Social psychology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1535-7163.targ-11-cn04-01","doi":"https://doi.org/10.1158/1535-7163.targ-11-cn04-01","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.targ-11-cn04-01","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9476000070571899,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2034556951","https://openalex.org/W2019920149","https://openalex.org/W2163288426","https://openalex.org/W2125748363","https://openalex.org/W105663816","https://openalex.org/W2148561001","https://openalex.org/W2810947741","https://openalex.org/W2366498512","https://openalex.org/W2531911860","https://openalex.org/W2894139739"],"abstract_inverted_index":{"Abstract":[0],"The":[1,278,364,484,922],"last":[2],"two":[3],"decades":[4],"has":[5,74,179,620,787,808,841,931],"seen":[6],"a":[7,28,64,76,115,198,307,347,351,414,420,492,515,546,622,634,638,647,656,756,792,812,889,905,950],"substantial":[8],"change":[9],"in":[10,39,89,161,231,242,250,274,287,310,322,328,356,428,460,472,573,579,581,594,652,667,680,686,693,700,767,778,820,868,912,928,948,953,1006,1018,1022],"the":[11,14,25,51,68,83,90,105,156,184,188,213,262,275,288,302,311,332,376,384,408,497,500,507,519,524,543,574,584,589,600,607,653,661,672,681,705,737,752,843,894,913,937,954,1011,1047,1085,1100,1107,1127,1320],"approaches":[12,58],"to":[13,59,117,203,215,225,246,301,338,345,358,406,431,449,504,583,660,773,815,818,848,893,965,969,990,994,1010,1046,1060,1106,1182],"clinical":[15,60,87,604,623,1268],"development":[16,222,263],"of":[17,27,31,37,41,44,53,56,67,82,86,93,104,108,137,146,151,173,193,233,239,255,264,281,293,314,353,369,378,413,417,425,462,488,499,509,512,521,523,545,549,563,576,606,614,655,663,671,683,736,755,759,795,845,854,886,897,908,916,924,941,956,961,992,1028,1036,1043,1050,1068,1078,1087,1102,1111,1146,1177,1230,1303,1319],"drugs.":[18,363,418,996],"This":[19],"paradigm":[20],"shift":[21],"was":[22,141,1038],"instigated":[23],"by":[24,375,637,1020,1084,1305],"discovery":[26],"significant":[29,348],"number":[30,562,758],"highly":[32,890],"innovative":[33],"and":[34,46,72,79,128,211,259,261,284,291,297,335,395,401,411,454,480,486,518,542,588,707,721,745,775,781,803,830,838,860,903,985,1013,1032,1066,1076,1109,1115,1179,1263,1298,1326],"distinct":[35,719],"classes":[36],"molecules":[38],"terms":[40],"both":[42,249,294,858],"mechanism":[43],"action":[45],"chemical":[47],"structure,":[48],"along":[49],"with":[50,125,164,603],"deployment":[52],"an":[54,100,446,559,697,883],"array":[55],"new":[57],"trial":[61,121],"design.":[62],"Moreover,":[63],"rising":[65],"understanding":[66],"relationships":[69],"between":[70,1030],"pharmacokinetics":[71],"pharmacodynamics":[73],"encouraged":[75],"more":[77],"systematic":[78],"rigorous":[80,199],"analysis":[81],"potential":[84],"role":[85,248,286,309,349,699,907,1101],"pharmacology":[88],"day-to-day":[91],"management":[92],"patients.":[94],"Historically,":[95],"pharmacokinetic":[96,135,166,206,253,551],"studies":[97,880,1054],"have":[98,111,129,346,442,534,676,977,1070],"been":[99,535,677,809,978],"important":[101,443,698,1097],"integrated":[102],"component":[103],"various":[106,359],"stages":[107],"drug":[109,162,221,266,282,323,370,473,540,668,691,701,779,834,839,1147],"development,":[110,163],"demonstrated":[112],"utility":[113,1075],"as":[114,331,350,704,725,791,804,811],"guide":[116],"dose":[118],"escalation":[119],"strategies,":[120,228],"design":[122],"issues":[123],"associated":[124,1117],"dosing":[126,227],"frequency,":[127],"provided":[130,933],"pertinent":[131],"information":[132,935],"on":[133,219,496,633,643,936,1099,1234],"interindividual":[134,550,774],"variability":[136,355,471,552,777],"novel":[138],"agents.":[139,564],"It":[140,997],"previously":[142],"suggested":[143],"that":[144,187,197,212,304,591,688,695,871,899,1001],"lack":[145,232],"efficacy":[147,456],"and/or":[148,326,435,477,1025],"inadequate":[149],"safety":[150],"investigational":[152,859],"agents":[153,626],"are":[154,238,372,404,465,722,963,1003],"currently":[155,386,615,988],"primary":[157],"reasons":[158],"for":[159,445,468,491,514,537,558,571,627,783,980,1041,1082,1267],"attrition":[160,175,1131],"poor":[165],"properties":[167,254],"representing":[168],"only":[169],"less":[170],"than":[171,642],"10%":[172],"total":[174],"(1).":[176],"However,":[177],"it":[178],"become":[180,842,1072],"widely":[181],"appreciated":[182],"at":[183],"same":[185],"time":[186],"relatively":[189],"narrow":[190],"therapeutic":[191,312],"index":[192],"many":[194,532,846,957],"drugs":[195,256,316],"demands":[196],"effort":[200],"be":[201,873,966,991,999,1016],"made":[202,621],"characterize":[204],"their":[205,209,247,285,1116],"properties,":[207],"optimize":[208],"regimens,":[210],"failure":[214],"recognize":[216],"this":[217,243,569,869,1037],"early":[218],"during":[220],"may":[223,597,771],"lead":[224],"suboptimal":[226,816],"eventually":[229],"resulting":[230],"efficacy.":[234],"Drug":[235,1135,1261],"transporter":[236,324,339,463,951],"proteins":[237,427,464,715],"increasing":[240,561],"interest":[241],"context":[244],"due":[245,430],"processes":[251],"regulating":[252],"(absorption,":[257],"distribution,":[258,835],"elimination)":[260],"cellular":[265,289,690,753],"resistance":[267,840],"through":[268],"decreased":[269],"uptake":[270,290,692,754,797],"or":[271,645,731],"increased":[272],"efflux":[273,292,669],"target":[276,481],"organ.":[277],"ubiquitous":[279],"distribution":[280],"transporters,":[283,541,727,730,744,1093],"endogenous":[295],"compounds":[296],"xenobiotics":[298],"give":[299],"strength":[300],"supposition":[303],"transporters":[305,371,670,687,711,748,829,930,984,1029,1105,1262],"play":[306,696],"crucial":[308],"effects":[313,453,478],"multiple":[315,1112],"used":[317],"clinically.":[318],"In":[319,529,972],"particular,":[320],"variation":[321,578],"activity":[325,461],"expression":[327,423],"organs":[329],"such":[330,703,805],"intestine,":[333],"kidney,":[334],"liver,":[336],"leading":[337],"malfunction,":[340],"is":[341,553,630,650],"now":[342,554,849],"increasingly":[343],"recognized":[344],"determinant":[352],"intersubject":[354],"response":[357,817],"commonly":[360,723],"prescribed":[361],"oncology":[362,856,1113],"most":[365,613],"extensively":[366],"studied":[367],"class":[368],"those":[373],"encoded":[374],"family":[377],"ATP-binding":[379],"cassette":[380],"(ABC)":[381],"genes.":[382],"Among":[383,733],"48":[385],"known":[387,405,538,616,964,989],"ABC":[388,673,828,983],"gene":[389,502],"products,":[390],"ABCB1":[391,592,1231],"(P-glycoprotein),":[392],"ABCC1":[393],"(MRP1)":[394],"its":[396],"homologue":[397],"ABCC2":[398],"(MRP2;":[399],"cMOAT),":[400],"ABCG2":[402,580,1178],"(BCRP)":[403],"influence":[407,599],"oral":[409,901,1048],"absorption":[410,896,1049,1108],"disposition":[412,474,780,1110],"wide":[415],"variety":[416],"As":[419],"result,":[421],"variable":[422],"levels":[424],"these":[426,768,942,1014,1069,1079],"humans,":[429],"inherited":[432,684],"factors":[433,437,1300],"(pharmacogenetics)":[434],"environmental":[436],"(e.g.":[438],"drug-drug":[439],"interactions),":[440],"can":[441,750,1015],"consequences":[444],"individual's":[447],"susceptibility":[448],"certain":[450,929,970],"drug-induced":[451],"side":[452],"treatment":[455,819],"(2).":[457,709],"Inherited":[458],"differences":[459,1021],"occasionally":[466],"responsible":[467],"extensive":[469],"interpatient":[470],"(systemic":[475],"exposure)":[476],"(normal":[479],"tissue":[482,1023],"exposure).":[483],"importance":[485],"detectability":[487],"genetic":[489,577,665,1299],"variants":[490,685,1233],"given":[493,516],"protein":[494],"depends":[495],"contribution":[498,544,885],"variant":[501,527],"product":[503],"pharmacological":[505],"response,":[506],"availability":[508],"alternative":[510],"pathways":[511],"elimination":[513,629],"drug,":[517],"frequency":[520],"occurrence":[522],"least":[525],"common":[526],"allele.":[528],"recent":[530,566,785,866,973],"years,":[531,974],"substrates":[533],"identified":[536,788,810],"polymorphic":[539,639,648,891,1104],"genetically-determined":[547],"source":[548],"being":[555],"rapidly":[556,851],"established":[557],"ever":[560],"Various":[565],"publications":[567],"highlight":[568],"principle,":[570],"example":[572,1035,1083],"case":[575],"relation":[582],"gefitinib-induced":[585],"diarrhea":[586],"(3),":[587],"finding":[590],"polymorphism":[593],"cancer":[595],"patients":[596,821],"adversely":[598],"QTc-prolongation":[601],"observed":[602],"usage":[605],"cyclic":[608],"depsipeptide":[609],"romidepsin":[610],"(4).":[611],"Nonetheless,":[612],"cases":[617],"where":[618],"pharmacogenetics":[619],"impact":[624,833],"involve":[625],"which":[628],"critically":[631],"dependent":[632],"rate-limiting":[635],"breakdown":[636],"enzyme":[640,649],"rather":[641],"transport,":[644],"when":[646],"involved":[651,952],"formation":[654],"toxic":[657],"metabolite.":[658],"Similar":[659],"discoveries":[662],"functional":[664],"variations":[666],"family,":[674],"there":[675,1002],"considerable":[678],"advances":[679],"identification":[682],"facilitate":[689],"tissues":[694],"elimination,":[702],"liver":[706],"kidney":[708],"These":[710],"comprise":[712],"over":[713],"350":[714],"organized":[716],"into":[717,798,826,918],"51":[718],"families,":[720],"classified":[724],"passive":[726],"ion":[728],"coupled":[729],"exchangers.":[732],"these,":[734],"members":[735],"organic":[738,742,746],"anion-transporting":[739],"polypeptides":[740],"(OATP),":[741],"anion":[743],"cation":[747],"(OCT)":[749],"mediate":[751],"large":[757],"structurally":[760],"diverse":[761],"compounds.":[762],"Accordingly,":[763],"functionally":[764],"relevant":[765],"polymorphisms":[766],"influx":[769],"carriers":[770,832,911,987],"contribute":[772],"interethnic":[776],"response;":[782],"example,":[784,945],"work":[786],"OCT1":[789,806],"function":[790,940],"critical":[793],"regulator":[794],"imatinib":[796,823,1051,1264,1304],"chronic":[799],"myeloid":[800],"leukemia":[801],"cells,":[802,962],"malfunction":[807],"factor":[813],"contributing":[814],"receiving":[822],"(5).":[824],"Investigations":[825],"how":[827],"solute":[831,910,986],"toxicity,":[836],"efficacy,":[837],"focus":[844],"efforts":[847],"also":[850],"expand":[852],"knowledge":[853],"other":[855],"drugs,":[857],"approved.":[861],"Specific":[862],"examples":[863],"from":[864,878],"our":[865],"ventures":[867],"field":[870],"will":[872,1094],"presented":[874],"include":[875],"preliminary":[876],"data":[877],"preclinical":[879,1008],"indicating":[881],"(i)":[882],"unexpected":[884],"ABCC4":[887],"(MRP4),":[888],"transporter,":[892],"gastric":[895],"dasatinib":[898],"impacts":[900],"bioavailability,":[902],"(ii)":[904],"dominant":[906],"specific":[909],"intracellular":[914],"accumulation":[915],"sorafenib":[917],"human":[919,1092],"epidermal":[920],"keratinocytes.":[921],"use":[923,1056],"animal":[925],"models":[926,976,1089],"deficient":[927,947],"historically":[932],"invaluable":[934],"normal":[938],"physiological":[939],"proteins.":[943],"For":[944],"mice":[946,1059],"ABCB1,":[949],"extrusion":[955],"different":[958],"substances":[959],"out":[960],"extremely":[967],"sensitive":[968],"neurotoxins.":[971],"mouse":[975,1088],"generated":[979],"nearly":[981],"all":[982],"relevance":[993,1045],"anticancer":[995],"should":[998],"emphasized":[1000],"sometimes":[1004],"complications":[1005],"translating":[1007],"findings":[1009],"clinic,":[1012],"explained":[1017],"part":[1019],"localization":[1024],"substrate":[1026],"recognition":[1027],"humans":[1031],"animals.":[1033],"An":[1034],"recently":[1039],"reported":[1040],"OATPs":[1042],"putative":[1044],"(6).":[1052],"Future":[1053,1074],"could":[1055],"humanized":[1057],"transgenic":[1058],"possibly":[1061],"improve":[1062],"animal-to-human":[1063],"translational":[1064],"findings,":[1065],"some":[1067],"already":[1071],"available.":[1073],"refinement":[1077],"model":[1080],"systems,":[1081],"generation":[1086],"carrying":[1090],"mutant":[1091],"likely":[1095],"shed":[1096],"light":[1098],"individual":[1103],"products":[1114],"pharmacodynamic":[1118],"effects.":[1119],"References:":[1120],"1.":[1121],"Kola":[1122],"I,":[1123,1282],"Landis":[1124],"J.":[1125],"Can":[1126],"pharmaceutical":[1128],"industry":[1129],"reduce":[1130],"rates?":[1132],"Nat":[1133],"Rev":[1134],"Discov":[1136],"204;3:711\u201315.":[1137],"2.":[1138],"Franke":[1139,1202,1249,1277],"RM,":[1140,1203,1250,1278],"Gardner":[1141,1192],"ER,":[1142,1193],"Sparreboom":[1143,1172,1225,1245,1295],"A.":[1144,1296],"Pharmacogenetics":[1145,1176],"transporters.":[1148],"Curr":[1149],"Pharm":[1150],"Design":[1151],"2010;16:220\u201330.":[1152],"3.":[1153],"Cusatis":[1154],"G,":[1155,1252],"Gregorc":[1156],"V,":[1157,1167],"Li":[1158],"J,":[1159,1165,1254,1284],"Spreafico":[1160],"A,":[1161,1173,1226,1246],"Ingersoll":[1162],"RG,":[1163,1292],"Verweij":[1164,1253,1283],"Ludovini":[1166],"Villa":[1168],"E,":[1169],"Hidalgo":[1170],"M,":[1171],"Baker":[1174],"SD.":[1175],"adverse":[1180],"reactions":[1181],"gefitinib.":[1183],"J":[1184],"Natl":[1185],"Cancer":[1186,1239,1271,1327,1339],"Inst":[1187],"2006;98:1739\u201342.":[1188],"4.":[1189],"Sissung":[1190],"TM,":[1191],"Piekarz":[1194],"RL,":[1195],"Howden":[1196],"R,":[1197],"Chen":[1198],"X,":[1199],"Woo":[1200],"S,":[1201],"Clark":[1204],"JA,":[1205],"Miller-De":[1206],"Graff":[1207],"L,":[1208],"Steinberg":[1209],"SM,":[1210],"Venzon":[1211],"D,":[1212,1214],"Liewehr":[1213],"Kleeberger":[1215],"SR,":[1216],"Bates":[1217],"SE,":[1218],"Price":[1219],"DK,":[1220],"Rosing":[1221],"DR,":[1222],"Cabell":[1223],"C,":[1224],"Figg":[1227],"WD.":[1228],"Impact":[1229],"allelic":[1232],"QTc":[1235],"interval":[1236],"prolongation.":[1237],"Clin":[1238,1270,1307],"Res":[1240,1272],"2011;17:937\u201346.":[1241],"5.":[1242],"Eechoute":[1243,1275],"K,":[1244,1276],"Burger":[1247],"H,":[1248,1286],"Schiavon":[1251],"Loos":[1255,1279],"WJ,":[1256,1280],"Wiemer":[1257],"EA,":[1258],"Mathijssen":[1259,1293],"RH.":[1260],"treatment:":[1265],"implications":[1266],"practice.":[1269],"2011;17:406\u201315.":[1273],"6.":[1274],"Boere":[1281],"Gurney":[1285],"Scherkenbach":[1287],"LA":[1288],"Kim":[1289],"RB,":[1290],"Tirona":[1291],"RH,":[1294],"Environmental":[1297],"affecting":[1301],"transport":[1302],"OATP1A2.":[1306],"Pharmacol":[1308],"Ther":[1309,1340],"2011;89:816\u201320.":[1310],"Citation":[1311],"Format:":[1312],"{Authors}.":[1313],"{Abstract":[1314],"title}":[1315],"[abstract].":[1316],"In:":[1317],"Proceedings":[1318],"AACR-NCI-EORTC":[1321],"International":[1322],"Conference:":[1323],"Molecular":[1324],"Targets":[1325],"Therapeutics;":[1328],"2011":[1329],"Nov":[1330],"12-16;":[1331],"San":[1332],"Francisco,":[1333],"CA.":[1334],"Philadelphia":[1335],"(PA):":[1336],"AACR;":[1337],"Mol":[1338],"2011;10(11":[1341],"Suppl):Abstract":[1342],"nr":[1343],"CN04-01.":[1344]},"counts_by_year":[],"updated_date":"2026-07-14T23:27:15.235271","created_date":"2016-06-24T00:00:00"}